New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
16:32 EDTAMRNAmarin is making progress expanding patent protection for Vascepa
Amarin continues to make significant progress in its effort to expand patent protection for Vascepa and now has 18 patents issued or allowed with over 30 additional patent applications being prosecuted in the United States. This patent portfolio includes claims covering key elements of Vascepa's pharmaceutical composition and methods of use for the MARINE indication, ANCHOR indication and other potential uses of Vascepa. Amarin is also pursuing patent applications related to Vascepa in multiple jurisdictions outside the United States. Amarin's goal is to protect the commercial potential of Vascepa beyond 2030. Patent protection for Vascepa is augmented by protection provided by trade secrets, taking advantage of manufacturing barriers to entry and regulatory exclusivity
News For AMRN From The Last 14 Days
Check below for free stories on AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
11:20 EDTAMRNHigh option volume stocks:
High option volume stocks: AMRN EWT HIMX PTEN URBN MTW VPRT MTH OTEX ZLTQ
09:26 EDTAMRNOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTAMRNAmarin up 12% to $1.78 after positive mention by Adam Feuerstein
Subscribe for More Information
09:10 EDTAMRNAmarin mentioned positively by The Street's Adam Feuerstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use